In the news
When off-label may mean off-target: How would doctors and insurers navigate demand for a new, narrow Alzheimer’s drug?
October 13, 2020STAT News
Related news
In the news
July 12, 2024
Study Shows 85% Of Patients Discontinue GLP-1s For Weight Loss After 2 Years
Forbes
In the news
July 11, 2024
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later
U.S. News & World Report